By S.D. Wells<\/p>\n\n\n\n If you never did before, now is the time to raise serious concerns about thimerosal (a mercury-containing preservative) in vaccines. The ACIP (Advisory Committee on Immunization Practices) is downplaying risks despite calls from multiple agencies (CDC, FDA, NIH, etc.) to remove it.<\/p>\n\n\n\n Thimerosal Safety Controversy<\/strong>: Critics argue that official safety assurances (CDC, ACIP) ignore documented risks of thimerosal, a mercury-based preservative linked to neurotoxicity, developmental harm and other serious health issues \u2014 especially in infants and pregnant women.<\/p>\n\n\n\n The upcoming ACIP vote could either address these concerns or maintain current policies, with new leadership potentially influencing the decision. The CDC has not clarified its stance<\/a>, fueling skepticism.<\/p>\n\n\n\n Key Points:<\/strong><\/p>\n\n\n\n The CDC\u2019s Advisory Committee on Immunization Practices (ACIP) will vote next week on whether to continue recommending flu vaccines containing thimerosal<\/a>, a mercury-based preservative, amid renewed scrutiny over its safety. The June 25-26 meeting in Atlanta marks the first since HHS Secretary Robert F. Kennedy Jr. replaced all 17 former ACIP members in a bid to restore public trust in vaccine policy. The panel will also decide on RSV vaccines for pregnant women and young children, despite clinical trial data showing an 11.71% rate of serious adverse events.<\/p>\n\n\n\n Thimerosal, used in multi-dose flu vaccine vials, has been a flashpoint in vaccine debates for decades. Though the CDC maintains it poses no harm, critics cite a 1999 internal meeting where officials acknowledged risks to infant brain development. In 2001, thimerosal was removed from childhood vaccines, yet it remains in some flu shots.<\/p>\n\n\n\n Dr. Meryl Nass, a longtime ACIP observer, stated, \u201cThere is no need for thimerosal, a known neurotoxin<\/a>, as it is not used in single-dose vials. Its use should be ended.\u201d Meanwhile, journalist Sharyl Attkisson\u2019s investigation challenged federal claims that thimerosal is safe, fueling calls for transparency.<\/p>\n\n\n\n The committee\u2019s focus on thimerosal has drawn polarized responses. Brian Hooker of Children\u2019s Health Defense criticized the CDC\u2019s \u201cbiased viewpoint,\u201d while Medpage editor Dr. Jeremy Faust called the vote a revival of \u201canti-vaccine conspiracy theories.\u201d Others, like researcher James Lyons-Weiler, see potential progress: \u201cIf safety data are rigorously evaluated, this could mark a turning point.\u201d<\/p>\n\n\n\n ACIP\u2019s recommendations often shape state vaccine mandates, yet its guidelines lack exhaustive safety data. Attorney Sujata Gibson noted that states like New York and California deny medical exemptions for conditions not listed in ACIP\u2019s framework, risking harm to vulnerable children.<\/p>\n\n\n\n Next week\u2019s vote could signal a shift in U.S. vaccine policy \u2014 or deepen existing divides. With thimerosal\u2019s safety back under scrutiny and new leadership at ACIP, the outcome may hinge on whether the committee prioritizes public trust or maintains the status quo. The CDC did not respond to requests for comment on whether it will clarify its guidelines\u2019 limitations.<\/p>\n\n\n\n Bookmark Vaccines.news<\/a> to your favorite independent websites for updates on toxic injections like the multi-dose flu jab and DTaP that STILL to this day contain mercury, listed as thimerosal in order to trick the populace.<\/p>\n\n\n\n Sources for this article include:<\/strong><\/p>\n\n\n\n![\"\"](\"https:\/\/www.naturalnews.com\/wp-content\/uploads\/sites\/91\/2025\/06\/Mercury-Metal-Vaccine-Shot-Syringe.jpg\")
<\/figure>\n\n\n\n\n
\n
CDC vaccine panel to vote on thimerosal in flu shots amid controversy over mercury safety<\/strong><\/h2>\n\n\n\n